GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » EPS (Diluted)

WDB coco Co (TSE:7079) EPS (Diluted) : 円320.84 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co EPS (Diluted)?

WDB coco Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円85.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円320.84.

WDB coco Co's EPS (Basic) for the three months ended in Dec. 2023 was 円85.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円321.64.

WDB coco Co's EPS without NRI for the three months ended in Dec. 2023 was 円85.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円320.97.

During the past 12 months, WDB coco Co's average EPS without NRIGrowth Rate was 12.30% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 28.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 29.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, WDB coco Co's highest 3-Year average EPS without NRI Growth Rate was 31.70% per year. The lowest was 21.60% per year. And the median was 28.50% per year.


WDB coco Co EPS (Diluted) Historical Data

The historical data trend for WDB coco Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co EPS (Diluted) Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
Get a 7-Day Free Trial 118.33 140.93 156.04 269.64 309.31

WDB coco Co Quarterly Data
Mar18 Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.63 82.20 67.37 86.23 85.04

Competitive Comparison of WDB coco Co's EPS (Diluted)

For the Health Information Services subindustry, WDB coco Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WDB coco Co's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where WDB coco Co's PE Ratio falls into.



WDB coco Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

WDB coco Co's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(743.625-0)/2.404
=309.33

WDB coco Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(204.747-0)/2.408
=85.03

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円320.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WDB coco Co  (TSE:7079) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


WDB coco Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of WDB coco Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co (TSE:7079) Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines